City

Indianapolis (2)

Condition

Neurofibromas (2)

Neurofibromatosis (2)

NF1 (1)

Overall Status

Completed (2)

Sign in for free

Phase

early phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Indiana University (1)

Kent Robertson (1)

Collaborator

Novartis (1)

Intervention

gleevec (1)

tasigna (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

neurofibromas

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Neurofibromatosis, Neurofibromas Trial in Indianapolis (Gleevec)

Completed

Neurofibromatosis
Neurofibromas

Gleevec

Indianapolis, Indiana

Riley Hospital for Children

Jun 2, 2017

Neurofibromatosis, NF1, Neurofibromas Trial in Indianapolis (Tasigna)

Completed

Neurofibromatosis
+2 more

Tasigna

Indianapolis, Indiana

Riley Hospital for Children

Apr 11, 2017